GSK
441724
This fixed-term role represents a great opportunity to work in the ViiV Healthcare Global Collaborative Studies Group, which currently supports over 120 investigator sponsored research (ISR) studies, generating important evidence to inform use of our products, and HIV in general, across the world.
In this role, you will lead, manage and implement the company related activities and accountabilities for ViiV Healthcare supported studies including investigator sponsored studies (ISS) and supported collaborative studies (SCS), ensuring timely review of study proposals and start up activities and compliance with relevant SOPs and policies from study start to completion.
The optimal candidate will be self-motivated, have a strong scientific and research background and experience working with external investigators and research networks, in addition to having good communication and organisation skills and a proven ability to lead in a matrix environment. The individual should have a desire to support evidence generation across the ViiV portfolio and a passion for contributing to the ViiV mission of leaving no person living with HIV behind.
Key responsibilities
Accountability
Why you?
Basic Qualifications
Preferred Qualifications
Experience in Medical Affairs and have current knowledge of HIV therapy area
Leadership experience in a matrix environment
Why ViiV?
ViiV Healthcare is a global specialty HIV company, the only company that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to leave no person living with HIV behind. We do this by being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care. We will push through every challenge until HIV/AIDS is eradicated.
ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV pandemic.
We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn't just somewhere to work - it's a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference.
While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities.
ViiV Healthcare is a company 100% focused on HIV that is majority owned by GSK, a global biopharma organization. As an employee of ViiV, you are part of a team united by a clear mission to leave no person living with HIV behind. Additionally, through our shareholder relationship with GSK, you have access to a range of shared benefits and career development opportunities.
Closing Date for Applications: Thursday 4th June 2026.
Please take a copy of the Job Description, as this will not be available post closure of the advert.
Why Us?
At ViiV Healthcare, we will not rest until we leave no person living with HIV behind. Until the 40 million people living with HIV is down to zero, we will continue searching for new ways to limit the impact of HIV.
We are the only pharmaceutical company solely focused on combating, preventing, and ultimately eradicating HIV and AIDS. At ViiV Healthcare, we do things differently. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, we are determined to help end the HIV...